Abate Kristin

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Abate Kristin's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-19 2026-10-16
S Sale
33,418 -32.9%
262.20
US$289,786 		33,418 -32.9% 262.20 US$289,786
2026-10-02 2026-10-01
S Sale
55,938 +39.2%
183.90
US$209,296 		55,938 +39.2% 183.90 US$209,296
2026-09-02 2026-09-01
S Sale
56,655 -25.7%
275.19
US$228,687 		56,655 -25.7% 275.19 US$228,687
2026-05-15 2026-05-14
S Sale
53 -0.2%
9.50
US$504 		53 -0.2% 9.50 US$504
2026-03-03 2026-03-02
S Sale
559 -2.5%
9.41
US$5,260 		559 -2.5% 9.41 US$5,260
2026-01-29 2026-01-28
S Sale
50 -0.2%
7.03
US$352 		50 -0.2% 7.03 US$352
2026-01-22 2026-01-21
S Sale
265 -1.2%
5.96
US$1,579 		265 -1.2% 5.96 US$1,579
2025-10-03 2025-10-01
S Sale
362 -3.5%
6.30
US$2,279 		362 -3.5% 6.30 US$2,279
2025-09-16 2025-09-15
S Sale
23 -0.2%
6.43
US$148 		23 -0.2% 6.43 US$148
2025-09-04 2025-09-03
S Sale
12 -0.1%
6.78
US$81 		12 -0.1% 6.78 US$81
2025-07-23 2025-07-22
S Sale
238 -2.5%
4.00
US$952 		238 -2.5% 4.00 US$952
2025-03-06 2025-03-04
S Sale
571 -5.6%
6.29
US$3,592 		571 -5.6% 6.29 US$3,592